共 154 条
[1]
Rawshani A(2017)Mortality and cardiovascular disease in type 1 and type 2 diabetes N Engl J Med 376 1407-1418
[2]
Rawshani A(2013)Vascular complications of diabetes: mechanisms of injury and protective factors Cell Metab 17 20-33
[3]
Franzen S(2020)Japanese clinical practice guideline for diabetes 2019 Diabetol Int 11 1020-1076
[4]
Rask-Madsen C(2018)Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 61 2461-2498
[5]
King GL(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
[6]
Araki E(2022)Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 65 1925-1966
[7]
Goto A(2023)6. Glycemic targets: standards of care in diabetes-2023 Diabetes Care 46 S97-S110
[8]
Kondo T(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412
[9]
Davies MJ(1995)The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial Diabetes 44 968-983
[10]
D’Alessio DA(2008)Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545-2559